Thomas A Thomson
Overview
Explore the profile of Thomas A Thomson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
98
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ko J, Klimowicz A, Jagdis A, Phan T, Laskin J, Lau H, et al.
Head Neck
. 2015 Feb;
38 Suppl 1:E384-91.
PMID: 25640951
Background: In advanced nasopharyngeal carcinoma (NPC), biomarkers may help predict survival. Methods: Tumoral expression of ataxia-telangiectasia mutated (ATM), thymidylate synthetase (THMS), and ribonucleotide reductase subunit M1 (RRM1), was correlated with...
2.
Kulic I, Robertson G, Chang L, Baker J, Lockwood W, Mok W, et al.
J Exp Med
. 2014 Dec;
212(1):37-52.
PMID: 25512468
Aberrant Notch activity is oncogenic in several malignancies, but it is unclear how expression or function of downstream elements in the Notch pathway affects tumor growth. Transcriptional regulation by Notch...
3.
Hao D, Phan T, Jagdis A, Siever J, Klimowicz A, Laskin J, et al.
Clin Invest Med
. 2014 Oct;
37(5):E320-30.
PMID: 25282138
Purpose: Aberrant expression of proteins involved in epithelial-to-mesenchymal transition have been described in various cancers. In this retrospective study, we sought to evaluate E-cadherin, β-catenin and vimentin protein expression in...
4.
Jagdis A, Phan T, Klimowicz A, Laskin J, Lau H, Petrillo S, et al.
Int J Radiat Oncol Biol Phys
. 2012 Nov;
85(5):1340-5.
PMID: 23182703
Purpose: We sought to evaluate the prognostic/predictive value of ERCC1 and XPF in patients with nonmetastatic nasopharyngeal carcinoma (NPC) treated with curative intent. Methods And Materials: ERCC1 and XPF protein...
5.
Gater A, Thomson T, Strandberg-Larsen M
Thromb Haemost
. 2011 Aug;
106(3):398-404.
PMID: 21833450
Worldwide, haemophilia is the most common hereditary bleeding disorder. The incidence of haemophilia B, however, is considerably less than haemophilia A and consequently appears to have received less attention in...
6.
Thomson T, Klijanienko J, Couturier J, Brisse H, Pierron G, Freneaux P, et al.
Cancer Cytopathol
. 2011 Feb;
119(1):49-57.
PMID: 21319312
Background: Rhabdoid tumors (RT) are rare, renal or extrarenal, high-grade malignancies. The cytologic diagnosis may be confirmed if combined with genomic results. In the current study, the authors present the...
7.
Thomson T, Zhou C, Ceballos K, Knight B
Am J Clin Pathol
. 2010 May;
133(6):909-14.
PMID: 20472849
Clinical use of tissue microarrays for immunohistochemical analysis of breast biomarkers, namely estrogen receptor, progesterone receptor, and HER2, was instituted in our laboratory in 2008. The method has proved reliable...
8.
Thomson T, Zhou C, Chu C, Knight B
Am J Clin Pathol
. 2009 Nov;
132(6):899-905.
PMID: 19926582
Tissue microarray analysis (TMA) allows multiple analyses on multiple patients on sections from a single paraffin block. Although it is widely used in research and in quality assurance settings, there...
9.
Thomas C, Bainbridge T, Thomson T, McGahan C, Morris W
Brachytherapy
. 2007 Apr;
6(2):135-41.
PMID: 17434107
Purpose: To evaluate the clinical impact of pathology review before prostate brachytherapy. Methods And Materials: Original and reviewing pathologists' reports were retrospectively collected from 1323 men treated with prostate brachytherapy...